Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison of two methods for estimating absolute risk of prostate cancer based on single nucleotide polymorphisms and family history.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Apr 2010

Hsu Fang-Chi, Sun Jielin, Zhu Yi, Kim Seong-Tae, Jin Tao, Zhang Zheng, Wiklund Fredrik, Kader A Karim, Zheng S Lilly, Isaacs William, Grönberg Henrik, Xu Jianfeng

Abstract excerpt

Disease risk-associated single nucleotide polymorphisms (SNP) identified from genome-wide association studies have the potential to be used for disease risk prediction. An important feature of these risk-associated SNPs is their weak individual effect but stronger cumulative effect on disease ris...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Area Under Curve
Share to Epidemiologic Methods

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome-Wide Association Study

Share to Odds Ratio

Share to Pedigree

Share to Prostatic Neoplasms

Share to Risk Factors

Share to ROC Curve

Source

Open in PubMed Open full text

Identifiers

PMID: 20332264
DOI: 10.1158/1055-9965.EPI-09-1176
PMCID: PMC2852494

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20332264-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of two methods for estimating absolute risk of prostate cancer based on single nucleotide polymorphisms and family history.PMID 20332264Read ↗

Estimation of absolute risk for prostate cancer using genetic markers and family history.Semantic proximity Read ↗

Genetic variants and family history predict prostate cancer similar to prostate-specific antigen.Semantic proximity Read ↗

Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer.Semantic proximity Read ↗

A comparison of genetic risk score with family history for estimating prostate cancer risk.Semantic proximity Read ↗

Clinical validity and utility of genetic risk scores in prostate cancer.Semantic proximity Read ↗

Comprehensive Analysis of Multiple Cohort Datasets Deciphers the Utility of Germline Single-Nucleotide Polymorphisms in Prostate Cancer Diagnosis.Semantic proximity Read ↗

Development and validation of a simple prostate cancer risk prediction model based on age, family history, and polygenic risk.Semantic proximity Read ↗

A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact.Semantic proximity Read ↗

Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort study.Semantic proximity Read ↗

Combining 33 genetic variants with prostate-specific antigen for prediction of prostate cancer: longitudinal study.Semantic proximity Read ↗

Does genotyping of risk-associated single nucleotide polymorphisms improve patient selection for prostate biopsy when combined with a prostate cancer risk calculator?Semantic proximity Read ↗

Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.